HULA Therapeutics Wins $250,000 Investment at PABC’s 10th Annual Entrepreneur Spotlight HULA Therapeutics, a Philadelphia-based biotech startup, has won a $250,000 investment at the Pennsylvania Biotechnology Center’s 10th Annual Entrepreneur [….]
Weekly Quick Hits (Greater Philly) – Week of May 8, 2023 By Mark TerryMay 12, 2023 Funding, Awards and Collaborations Interius Announces Manufacturing Partnership with WuXi Advanced Therapies Philadelphia-based Interius [….]
Wistar, Pennsylvania Biotechnology Center and Blumberg Institute Partner to Accelerate Philly Life Sciences By Mark Terry May 11, 2023 Three Philadelphia-based life sciences organizations have formed a strategic collaboration to [….]
Coming off an election cycle where workforce development in Pennsylvania was a priority for the incoming governor and US Senator from Pennsylvania, a suburban Philadelphia biotech center is getting a few million from the state for early-stage startups.
Doylestown-based Pennsylvania Biotechnology Center (PABC), which guides more than 100 member companies through scientific discoveries and commercialization, is the recipient of a $5 million investment from the State of Pennsylvania’s Department of Health. The funds will go toward PABC’s new Academic Innovation Zone program, which will support early-stage companies and academic technologies in life sciences in two of its incubator programs. PABC is headquartered in Bucks, but also works with B+labs at Philadelphia’s Cira Centre, in partnership with Brandywine Realty Trust.
